Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Status:
Terminated
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate how epratuzumab is processed by the body
(pharmacokinetics) and whether 2 dose levels of epratuzumab are safe and effective in
patients with SLE.